Xeris Biopharma Holdings, Inc. (XERS) › Operating Cash FlowXeris Biopharma Holdings, Inc. (XERS) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2020: -$80.56M2021: -$95.53M2022: -$102.89M2023: -$47.02M2024: -$36.98M2025: $28.63M$28.63M2020Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$28.63M+177.4%2024-$36.98M+21.4%2023-$47.02M+54.3%2022-$102.89M-7.7%2021-$95.53M-18.6%2020-$80.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share